Previous studies have shown that LPS may be able to induce NF-κB activation in colon and pancreatic cancer cells [30,31], which strongly suggests that LPS can act not only on immune cells but also on some cancer cells from epithelial cells. Here, NFKB1 is linked to familial pancreatic carcinoma.